Financing

Castlight Health prices its IPO financing

Posted on 17 March 2014

Tags: , , ,

Castlight Health is to raise $176 million in IPO financing.

Castlight Health announced the pricing of its initial public offering of 11,100,000 shares of its Class B common stock at a price to the public of $16.00 per share.

Castlight Health has granted the underwriters a 30-day option to purchase up to 1,665,000 additional shares of Class B common stock from Castlight Health at the initial public offering price.

The shares are expected to begin trading on the New York Stock Exchange on March 14, 2014 under the symbol “CSLT.”

For further financing deal information visit Current Agreements (subscription required)

 

Related

Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary

View: Current Partnering’s Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
e80banner300x150animgif
a1banner300x150animgif